Skoči na glavni sadržaj

Ostalo

https://doi.org/10.15836/ccar2022.309

Invasive treatment of patients with atrial fibrillation and high risk of bleeding

Matija Mlinar orcid id orcid.org/0000-0002-0212-7924
Zvonimir Katić orcid id orcid.org/0000-0002-0493-3188


Puni tekst: engleski pdf 132 Kb

str. 309-309

preuzimanja: 83

citiraj

Preuzmi JATS datoteku


Sažetak

Ključne riječi

atrial fibrillation; pulmonary vein isolation; left atrial appendage occluder

Hrčak ID:

289870

URI

https://hrcak.srce.hr/289870

Datum izdavanja:

8.12.2022.

Posjeta: 201 *



Atrial fibrillation (AF) is the most common long-term cardiac arrhythmia found in a wide population of people and is closely associated with an increased risk of death, cerebrovascular insult and other thromboembolic incidents (1). Based on the symptoms and duration of AF, physicians choose a treatment strategy, which can be a frequency control strategy or a rhythm control strategy. In the patient whose case we have described, a rhythm control strategy was chosen, which was carried out with antiarrhythmic therapy and isolation of the pulmonary veins (2). Likewise, in patients with AF, it is necessary to choose the correct anticoagulation therapy. The guidelines emphasize the assessment of risk factors for a thromboembolic event using the Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65–74, Female or CHA2DS2-VASc score. Also, the risk of bleeding should be considered, and for this purpose the Hypertension, Abnormal liver/renal function, Stroke history, Bleeding history or predisposition, Labile INR, Elderly, Drug/alcohol usage or HAS-BLED scoring system is used. In the patient whose case we have described, in addition to cryoablation of the pulmonary veins, an occluder of the left atrial appendage (LAAO) was placed in the same act.

LITERATURE

1 

Lovrić Benčić, M. Fibrilacija atrija – najčešća postojana aritmija. Medicus, 2016;25(2 Kardiologija danas);167-76.

2 

Sagris M, Vardas EP, Theofilis P, Antonopoulos AS, Oikonomou E, Tousoulis D. Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics. Int J Mol Sci. 2021 December 21;23(1):6. https://doi.org/10.3390/ijms23010006 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/35008432


This display is generated from NISO JATS XML with jats-html.xsl. The XSLT engine is libxslt.